CYD
Price
$23.87
Change
-$1.62 (-6.36%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
956.34M
25 days until earnings call
Intraday BUY SELL Signals
ENOV
Price
$21.58
Change
+$0.77 (+3.70%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
1.2B
14 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CYD vs ENOV

CYD vs ENOV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CYD vs. ENOV commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYD is a Hold and ENOV is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CYD with price predictions
Oct 22, 2026

CYD in -2.77% downward trend, sliding for three consecutive days on October 20, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CYD declined for three days, in 183 of 262 cases, the price declined further within the following month. The odds of a continued downward trend are 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CYD turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 27 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 69%.

The Aroon Indicator for CYD entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +5.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where CYD advanced for three days, in 215 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

CYD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.094) is normal, around the industry mean (1.879). P/E Ratio (1.307) is within average values for comparable stocks, (13.642). Projected Growth (PEG Ratio) (0.372) is also within normal values, averaging (2.450). Dividend Yield (0.137) settles around the average of (0.154) among similar stocks. P/S Ratio (0.324) is also within normal values, averaging (2.648).

The Tickeron SMR rating for this company is 61 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 75 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. CYD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for ENOV with price predictions
Oct 22, 2026

ENOV's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for ENOV turned positive on September 23, 2026. Looking at past instances where ENOV's MACD turned positive, the stock continued to rise in 33 of 44 cases over the following month. The odds of a continued upward trend are 75%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on ENOV as a result. In 44 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.

ENOV moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where ENOV advanced for three days, in 156 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for ENOV moved below the 200-day moving average on September 25, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

ENOV broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ENOV entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. ENOV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.812) is normal, around the industry mean (2.874). P/E Ratio (-1.078) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (3.441) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.466) is also within normal values, averaging (40.124).

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
CYD vs ENOV: Fundamental Ratings
CYD
ENOV
OUTLOOK RATING
1..100
5927
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
78
Overvalued
PROFIT vs RISK RATING
1..100
75100
SMR RATING
1..100
6198
PRICE GROWTH RATING
1..100
8659
P/E GROWTH RATING
1..100
9618
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYD's Valuation (44) in the Trucks Or Construction Or Farm Machinery industry is somewhat better than the same rating for ENOV (78) in the Industrial Machinery industry. This means that CYD’s stock grew somewhat faster than ENOV’s over the last 12 months.

CYD's Profit vs Risk Rating (75) in the Trucks Or Construction Or Farm Machinery industry is in the same range as ENOV (100) in the Industrial Machinery industry. This means that CYD’s stock grew similarly to ENOV’s over the last 12 months.

CYD's SMR Rating (61) in the Trucks Or Construction Or Farm Machinery industry is somewhat better than the same rating for ENOV (98) in the Industrial Machinery industry. This means that CYD’s stock grew somewhat faster than ENOV’s over the last 12 months.

ENOV's Price Growth Rating (59) in the Industrial Machinery industry is in the same range as CYD (86) in the Trucks Or Construction Or Farm Machinery industry. This means that ENOV’s stock grew similarly to CYD’s over the last 12 months.

ENOV's P/E Growth Rating (18) in the Industrial Machinery industry is significantly better than the same rating for CYD (96) in the Trucks Or Construction Or Farm Machinery industry. This means that ENOV’s stock grew significantly faster than CYD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYDENOV
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
62%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
55%
MACD
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
65%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
63%
Advances
ODDS (%)
Bullish Trend 14 days ago
75%
Bullish Trend 1 day ago
61%
Declines
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 15 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
66%
Aroon
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
69%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (CYD: $25.49 vs. ENOV: $20.81)
Brand notoriety: CYD and ENOV are both not notable
CYD represents the Motor Vehicles, while ENOV is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CYD: 111% vs. ENOV: 75%
Market capitalization -- CYD: $956.34M vs. ENOV: $1.2B
CYD [@Motor Vehicles] is valued at $956.34M. ENOV’s [@Medical/Nursing Services] market capitalization is $1.2B. The market cap for tickers in the [@Motor Vehicles] industry ranges from $669 to $1.48T. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Motor Vehicles] industry is $76.33B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYD’s FA Score shows that 0 FA rating(s) are green while ENOV’s FA Score has 1 green FA rating(s).

  • CYD’s FA Score: 0 green, 5 red.
  • ENOV’s FA Score: 1 green, 4 red.
According to our system of comparison, both CYD and ENOV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYD’s TA Score shows that 4 TA indicator(s) are bullish while ENOV’s TA Score has 5 bullish TA indicator(s).

  • CYD’s TA Score: 4 bullish, 3 bearish.
  • ENOV’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CYD is a better buy in the short-term than ENOV.

Price Growth

CYD (@Motor Vehicles) experienced а -4.06% price change this week, while ENOV (@Medical/Nursing Services) price change was +12.06% for the same time period.

The average weekly price growth across all stocks in the @Motor Vehicles industry was -8.84%. For the same industry, the average monthly price growth was -18.38%, and the average quarterly price growth was -33.21%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

Reported Earning Dates

CYD is expected to report earnings on Nov 16, 2026.

ENOV is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Motor Vehicles (-8.84% weekly)

Automobiles continue to be arguably the most popular form of passenger travel in the U.S., and major automobile makers have revenues and market capitalizations running into multi-billions. In recent years, the industry has been experiencing some path-breaking innovations like electric vehicles and self-driving technology. While there are long-standing companies like General Motors, Ford, and Toyota Motors operating in this space, there are also emerging/rapidly growing players like Tesla – which has had a major role in the growing popularity of the electric vehicle market. With technological advancements taking steam in the auto space, we’ve also witnessed collaborations (or talks of potential partnerships) of carmakers with tech behemoths like Google’s subsidiary, Waymo.

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
CYD
Daily Signal:
Gain/Loss:
ENOV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CYD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYD has been loosely correlated with TNC. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CYD jumps, then TNC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYD
1D Price
Change %
CYD100%
-6.28%
TNC - CYD
34%
Loosely correlated
+1.18%
CXT - CYD
33%
Poorly correlated
+3.61%
ENOV - CYD
30%
Poorly correlated
+3.75%
LXFR - CYD
28%
Poorly correlated
-0.23%
HLMN - CYD
27%
Poorly correlated
+1.38%
More

ENOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with FELE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then FELE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENOV
1D Price
Change %
ENOV100%
+3.75%
FELE - ENOV
56%
Loosely correlated
-2.01%
DOV - ENOV
55%
Loosely correlated
-2.18%
PH - ENOV
53%
Loosely correlated
-6.78%
ITT - ENOV
52%
Loosely correlated
-6.03%
KMT - ENOV
51%
Loosely correlated
-4.89%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTIS75.603.25
+4.49%
Otis Worldwide Corp
PSEC1.490.02
+1.36%
Prospect Capital Corp
UPLD3.660.01
+0.27%
Upland Software
HP37.13-1.12
-2.93%
Helmerich & Payne
AKBA0.56-0.02
-3.95%
Akebia Therapeutics